baber/WOPTO huggingface dataset:
Patent NZ-513741-A (NZ)
Title: Skin wrinkle reduction using pulsed light
Inventor: KIERNAN MICHAEL NOEL
IPC: A61B18/20
Filed: 2000-03-03
Abstract: Wrinkles are cosmetically removed from a superficial area of mammalian skin tissue having an epidermal layer (1), a basal layer (2), and a dermal layer (3), by irradiating the dermal layer (3) through the basal layer (2), the irradiation (7) having an energy density in the range 5J/cm2 or less, and being selected to be absorbed by a chromophore in the dermal layer (3) such that collagen present in the dermal layer (3) is heated, while the basal layer (2) remains intact so as to substantially inhibit contact of the dermal layer (3) with ambient air.
Patent NZ-514632-A (NZ)
Title: Collapsible, stackable, self-supporting container
Inventor: HUPP MATTHEW TODD
IPC: B65D1/22
Filed: 2000-04-11
Abstract: A stackable, self-supporting container comprising: (a) a semi-enclosed container body including a tubular structure having two open ends and a bottom panel enclosing one end of the container body, the other end of the tubular structure opposite from the bottom panel forming a substantially continuous outwardly-extending peripheral flange, the tubular structure including two opposed side walls, two opposed end walls between the side walls, the side walls and said end walls together forming the tubular structure, each of the end walls including a central portion and a pair of opposing supporting flaps hingedly connected to the central portion and moveable between a position substantially planar with the central portion and a position substantially perpendicular with the central portion; (b) a lid for selectively converting the semi-enclosed container to a closed container; and (c) a closure element for sealing said lid to the container body. The closure element preferably includes a mechanical interlocking seal, and the supporting flaps are preferably unitarily formed with the central portion and preferably lock in the perpendicular position.
Patent NZ-518195-A (NZ)
Title: Non-covalent inhibitors of urokinase and blood vessel formation
Inventor: LEVY ODILE ESTHER
IPC: A61P35/00
Filed: 2001-08-10
Abstract: Disclosed are compounds of formula (I), wherein: X is -S(O)2-, N(R)-S(O)2-, -(C=O)-, -OC(=O)-, -NH-C(=O)-, -P(O)(R')-, or a direct link, R1 is optionally substituted alkyl, cycloalkyl, heterocycloalkyl, heterocyclo, alkenyl, aryl, heteroaryl, aralkyl, heteroaralkyl, aralkenyl, hetroaralkenyl, C9-15fused carbocycle, difluoromethyl, perfluoroalkyl, perfluoroaryl, perfluoroaralkyl, or H, R2 is -CH2OH, -CH(CH3)OH, or selected to give a group at P3 of acyl or carbonate esters of D-seryl, R3 and R4 together give a group at P2 of prolyl, pipecolyl, azetidine-2-carbonyl, 4-hydroxyprolyl, 3-hydroxyprolyl, 3,4-methanoprolyl or 3,4-dehydroprolyl, R7 is H or alkyl, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of conditions ameliorated by inhibiting or decreasing urokinase activity or angiogenesis in a mammal.
Patent NZ-520518-A (NZ)
Title: Process to remove lignin from lignocellulose material by first treating with a oxygen containing delignifying gas before a mechanical pulping process
Inventor: BRYANT PATRICK S
IPC: D21C1/04
Filed: 2001-02-08
Abstract: A process for the removal of lignin from lignocellulose containing material comprises treating the lignocellulose containing material prior to a high-yield pulping process with a delignifying gas comprising chlorine dioxide
Patent NZ-523635-A (NZ)
Title: Flotation mechanism and method for dispersing gas and controlling flow in a flotation cell
Inventor: JOUNELA SEPPO
IPC: B03D1/16
Filed: 2001-07-19
Abstract: The invention relates to a flotation mechanism (4) comprising a directional element (25) and vertical vanes (26) located in a flotation cell. The directional element is symmetrical and is fixed at the centre to the lower section of the hollow shaft of the mechanism. According to the corresponding method, due to the directional element (25), which is cylindrically inclined downwards from the outer edge the flotation mechanism directs the gas-slurry suspension that is formed in a downward slanting direction towards the side wall of the cell. The mineral suspension rises upwards from the side wall towards the centre of the cell, from where the flow is diverted to the edges of the cell and the froth generated is removed from the cell. Using this flotation mechanism enables a powerful agitation, extending throughout the entire mixing zone.
Patent NZ-524101-A (NZ)
Title: Neuroprotective 2-pyridinamine compositions and related methods for reducing ischemic death of cells or neuronal cell death
Inventor: GRANT ELFRIDA R
IPC: A61P25/28
Filed: 2001-08-06
Abstract: Neuroprotective pharmaceutical compositions comprising 2-pyridinaminesor their salts of formula (I) and methods of using these compositions to prevent ischemic cell death, particularly neuronal cell death, and reduce the likelihood of neuronal cell death in a subject due to a traumatic event are disclosed, wherein: (a) R1 is H or a substituent bound at either the 5 or 6 ring position and selected from the group consisting of alkyl, alkenyl, alkynyl, thienyl, furanyl, pyrrolyl, phenyl, pyrimidinyl, substituted pyrimidinyl, pyridinyl, substituted pyridinyl, phenyl alkenyl, substituted phenyl alkenyl, benzo[b] thien-2-yl, 2-benzofuranyl and substituted phenyl, said substituted phenyl having the formula as described in the specification; wherein (i) R6 is selected from the group consisting of H, OH, halogen, alkylamino, dialkylamino, hydroxy-substituted dialkyl amino, lower alkyl, acidic lower alkyl, alkoxy, halogen-substituted lower alkoxy, phenyl and morpholinyl, and (ii) R7 represents between one and four substituents which may be the same or different and are selected from the group consisting of H, halogen, amino, alkyl, lower alkyl, halogen substituted lower alkyl, alkylamino, dialkylamino, acidic lower alkoxy, alkoxy, halogen-substituted lower alkoxy, alkoxy and phenylalkoxy, with the proviso that R6 and R7 may be fused to form 2-naphthyl or 1,3, benzodioxolyl; (b) Each R2 is independently H or lower alkyl ; (c) Each R3 is independently selected from the group consisting of H, lower alkyl, amino, alkylamino, dialkylamino and lower alkoxy; (d) R4 is H, alkoxy or morpholinyl, with the proviso that R4 may be fused with R3 to form 2,3-dihydro-1,4-benzodioxinyl or 9-alkyl 9H carbazolyl; and (e) R5 is H or lower alkyl. Also disclosed is an apparatus such as a pre filled syringe for administering to a subject the instant pharmaceutical compositions.
Patent NZ-530738-A (NZ)
Title: Methods and systems for compositing images
Inventor: LIND DANIEL RICHARD JAMES
IPC: G06T15/00
Filed: 2004-01-21
Abstract: To form an approximation of a three-dimensional (3-D) image of a first object such as a hair style on a head using images obtained from the first object, a plurality of images of the object from multiple positions about a horizontal plane are obtained, and foreground and background layers of the object are created within these images. A 3-D image of the object is obtained from the plural images and converted into a format suitable for compositing with another 3-D image so that different virtual hairstyles on the subject's head can be shown to the subject.
Patent NZ-531822-A (NZ)
Title: A membrane pump
Inventor: GRAPES ROBERT DONALD
IPC: F04B43/06
Filed: 2004-03-18
Abstract: A pump that has a cavity (13) in which is located a flexible membrane (14) mounted with a pre-set such that it is bi-stable, in each stable state the membrane conforming to the shape of one of the opposing surfaces of the cavity. An inlet opens into the cavity and is associated with a valve (27). A valve (28) is likewise provided in an outlet (25). Also opening into cavity is a port (22) to which means for applying negative and positive pressures can be connected whereby the flexible membrane can be moved to its two stable states corresponding to completion of inlet and exhaust of a pumping cycle.
Patent NZ-534383-A (NZ)
Title: Polyvinylacetal resin and process for its production
Inventor: MASHIKO YOSHIHIRO
IPC: C08F16/38
Filed: 2003-02-07
Abstract: Disclosed herein is a particulate polyvinylacetal resin porous powder of low metal content, being excellent in transparency, moisture resistance and electrical resistance, and having a large specific area; and a process for producing the same. The polyvinylacetal resin porous powder is obtained by reacting polyvinyl alcohol and an aldehyde in the presence of an acid catalyst at a reaction temperature of from 20 to 50 Deg C, and it has an acetalization degree of at least 60 mol%, a specific surface area of from 1.50 to 3.50 m2/g, an average particle diameter of from 0.5 to 2.5 micron, bulk density of 0.12 to 0.19 g/cm3, and a metal content of 80 ppm or less. In particular, the particulate polyvinylacetal resin is produced for example, by feeding a reaction fluid containing polyvinyl alcohol, an aldehyde and an acid catalyst into a first reactor, carrying out an acetalization reaction until an acetalization degree of 10 to 60 mol%, discharging the reaction mixture, feeding the same into a second reactor and performing further reaction until the acetalization degree of polyvinylacetal resin is 65 mol% or higher.
Patent NZ-536005-A (NZ)
Title: Water desalinization process and apparatus using solar heating, condensation and the Venturi effect
Inventor: CIUDAJ JEFFREY
IPC: B01D3/34
Filed: 2003-04-30
Abstract: A process and device (1) for desalinizing water is disclosed. The process comprises of providing a blackened surface (16) in contact with a body of water (31) so as to heat air and evaporate the water from the blackened surface (16). The heated air and water vapour is channelled upward, through a vertical Venturi wind shaft (10), creating an adiabatic pressure variance. The heated air and water vapour are then released into a first chamber (6) of a series of interconnected chambers (5). The water vapour condenses (23) within the chambers (5) and drains to a series of basins (26) at the bottom of the chambers (5) which in turn drain to a reservoir (36). The heat from the air in the upper zone (17) of the chambers (5) is absorbed by a heat transfer duct (40) containing cool air collected off the body of water (31). The heated air in the duct (40) is then expelled out of the top of the structure along with the air that the water was extracted from by way of the air exhaust port (48).
Patent NZ-538577-A (NZ)
Title: A novel sewing machine for decoratively stitching a cricket ball
Inventor: SINGH HARDYAL
IPC: D05B23/00
Filed: 2002-08-23
Abstract: Disclosed is a sewing machine for decoratively stitching a cricket ball, said sewing machine comprising: A dual needle looper assembly comprising a plurality of needles place parallel to each other in an offset manner and being fixed onto a needle holder, said plurality of needles having corresponding loopers placed below the needles, said loopers being mounted on looper holders; Said dual needle looper assembly being mounted on reciprocating means; Said dual needle looper assembly being encased within a hemispherical hollow mandrel assemble having an opening/pores to allow reciprocating movement of the needles; Said hemispherical hollow mandrel assembly being mounted with a hemispherical leather cup on which decorative stitching is to be performed; Said hemispherical hollow mandrel mounted with the leather cup being freely mounted on a ball bearing support and being in contact with a ball holder; and Said ball holder is mounted on an indexer assembly to provide circular indexing movement to the hemispherical leather cup.
Patent NZ-539512-A (NZ)
Title: Extended controlled-release pharmaceutical compositions comprising charged polymers
Inventor: LEVINE HOWARD L
IPC: A61K31/192
Filed: 2003-04-25
Abstract: The disclosure relates to a delivery system for pharmaceutical compositions relying in part on an ionic interaction to control and facilitate release of the treating agent. More specifically, the disclosure relates to an extended controlled-release system having an ionic treating agent and an ionic polymer, wherein the polymer is sufficiently ionized to release the treating agent in a controlled manner over an extended period of time and the composition does not require an emulsion system for administering the treating agent.
Patent NZ-542545-A (NZ)
Title: Methods for adjusting the power of a gas-operated plural chambered apparatus, typically nailing gun, by operator adjustment of communication between chambers
Inventor: TOULOUSE BRUNO
IPC: B25C1/08
Filed: 2004-03-19
Abstract: The disclosure is applies to a gas-operated apparatus comprising a first chamber (11) for the pre-compression of a combustible gas (12) injected thereinto and generation of a flame, and a second, propulsion, chamber (15), and means (16, 17) for placing the two chambers in communication, these means being designed to allow the flame to pass, the power of the apparatus being adjusted by adjusting (17) the communication between the two chambers (11, 15). The volume of gas injected directly (42) into the propulsion chamber (15) can also be adjusted. Alternatively, the rotational speed of the fan (13) with which the first chamber (11) is equipped can be adjusted.
Patent NZ-542933-A (NZ)
Title: Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
Inventor: MILLER TIMOTHY J
IPC: C12N15/82
Filed: 2004-05-04
Abstract: Provided is a method for making an immunoprotective particle or a biologically active protein particle comprising the steps of: a) transforming a plant cell with a polynucleotide encoding at least one immunoprotective antigen or at least one biologically active protein; b) culturing said transformed plant cell under conditions that allow for the proliferation of said transformed plant cell and the accumulation of said immunoprotective antigen or said biologically active protein in said plant cell; c) collecting and washing said cultured transformed cells; d) resuspending said washed transformed cells in a lysis buffer containing no detergents or other chemical agents that disrupt cells; e) physically or mechanically disrupting said resuspended cells such that immunoprotective particles or biologically active protein particles are formed; f) separating cellular debris from said immunoprotective particles or said biologically active protein particles to form a solution comprising said immunoprotective particles or said biologically active particles; and (g) filtering said solution comprising immunoprotective particles or said biologically active particles to remove any bacterial contaminants. Further provided are compositions made by the method and various uses of the compositions.
Patent NZ-546096-A (NZ)
Title: Method and apparatus for placing sensors using 3D models
Inventor: ARPA AYDIN
IPC: H04N7/18
Filed: 2004-07-01
Abstract: A method and apparatus for dynamic sensor placement in a 3D model is disclosed. The method comprises: (a) positioning at least one sensory device in a scene of a 3D site model supported in a computer; (b) rendering, in the computer, an image of at least part of the scene of the 3D site model in which at least part of the coverage of at least one sensory device within the scene of the 3D site model is displayed, and part of the scene of the 3D site model outside the coverage is displayed, where the coverage is derived in accordance with sensor parameters associated with the sensory device; and (c) the rendering of the image being derived for a view point in the 3D site model that is different from the positioning of the sensory device, wherein the rendering step renders the coverage of the sensor in accordance with the sensor parameters such that surfaces in the 3D site model in the image have a texture that differentiates the coverage from the part of the scene that is not in the coverage.
Patent NZ-555889-A (NZ)
Title: Deacylation of LPS in gram negative bacteria
Inventor: TOMMASSEN JOHANNES PETRUS MARIA
Filed: 2005-12-16
Abstract: Disclosed is a Gram negative polypeptide exhibiting lipid A 3-O-deacylase activity and capable of modifying and/or detoxifying gram negative LPS. Also disclosed are Gram negative bacteria, Gram negative bacterial lipopolysaccharides (LPS) and compositions comprising LPS, which are provided with or treated with a 3-O-deacylase and which may be used for pharmaceutical and/or veterinary purposes, in particular for the preparation of whole cell or acellular vaccines against pathogenic Gram negatives such as Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.
Patent NZ-561100-A (NZ)
Title: Log rotation and verification system and method
Inventor: STREBIG PAUL W
IPC: B23Q15/00
Filed: 2006-03-13
Abstract: A log rotation system is disclosed. The system includes: an optimizer configured to determine an optimized cutting solution for a log to be processed and identify an optimized rotational position of the log for a determined processing step; a position indicator applicable to the log to initially indicate a reference rotational position of the log; a log rotator adapted to rotate the log to reduce a rotational difference between the reference rotational position and the optimized rotational position; and a primary detector configured to detect a current rotational position of the position indicator.
Patent NZ-564464-A (NZ)
Title: Traffic preemption system with headway management
Inventor: SCHWARTZ MARK A
IPC: G08G1/00
Filed: 2006-06-14
Abstract: A traffic pre-emption system and a method of managing headway of a mass-transit vehicle at a traffic location in a traffic pre-emption system are disclosed. The traffic pre-emption system comprises means for transmitting an identification code from a transmitter associated with a mass-transit vehicle; means for receiving the identification code at a receiver situated at a traffic location; means for identifying the mass-transit vehicle using the identification code; means for comparing a time of the mass-transit vehicle's arrival at the traffic location with a pre-determined schedule; means for determining a variance between the time of arrival and the predetermined schedule; and means for generating a traffic-pre-emption command for a traffic light based on the determined variance. The means for transmitting can comprises a transmitter that is adapted to transmit the identification code of the mass-transit vehicle. The traffic pre-emption system can comprises a traffic light circuit having receiver located at the traffic location and adapted to receive the identification code, and a decoding circuit adapted to attempt to identify the mass-transit vehicle using the identification code, compare the time of the mass-transit vehicle's arrival at the traffic location with the pre-determined schedule, and, in response to determining the variance between the time of arrival and the pre-determined schedule, generate the traffic pre-emption command for the traffic light. The traffic pre-emption system can comprises a controller provided at each one of a plurality of intersections; a respective second transceiver coupled to each controller and adapted to receive the transmitted identification code from the first transceiver and to transmit the encoded information to the first transceiver; and a respective decoding circuit coupled to each controller and adapted to attempt to identify the mass-transit vehicle using the identification code. The controller is adapted to compare the time of the mass-transit vehicle's arrival at the one of the intersections with the pre-determined schedule, and, in response to determining the variance between the time of arrival and the pre-determined schedule, generate the traffic-pre-emption command for the traffic light and transmit variance information to the mass-transit vehicle.
Patent NZ-569631-A (NZ)
Title: FGF receptor (FGF) agonist dimeric compounds, process for the preparation thereof and therapeutic use thereof
Inventor: BONO FRANCOISE
IPC: A61K31/435
Filed: 2007-01-12
Abstract: Disclosed are Fibroblast Growth Factor (FGF) receptor agonists of formula M1-L-M2, wherein L is an alkylene radical which links M1 and M2, and M1 and M2 are indolizine radicals represented by formula M. Also disclosed is the use of the above mentioned FGF receptor agonists for the preparation of a medicament. A process of preparing the said FGF receptor agonists is also disclosed.
Patent NZ-572467-A (NZ)
Title: Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
Inventor: ALBERS RONALD J
IPC: A61K31/52
Filed: 2007-04-25
Abstract: Disclosed is a method for treating and preventing insulin resistance, idiopathic pulmonary fibrosis, myelfibrosis, hepatic fibrosis, steatofibrosis or steatohepatitis in a non-human animal, comprising administering an effective amount of a haloaryl substituted aminopurine compound having the formula (I), wherein the substituents are as defined in the specification.
Patent NZ-573693-A (NZ)
Title: 3,5-Dihydro-pyridazino[4,5-b]indol-4-one and 2,5-dihydro-pyridazino[4,5-b]indol-1-one derivatives
Inventor: BECKNELL NADINE C
IPC: A61P35/00
Filed: 2007-06-22
Abstract: Disclosed are 3,5-dihydro-pyridazino[4,5-b]indol-4-one and 2,5-dihydro-pyridazino[4,5-b]indol-1-one derivatives as represented by the general formula (II), wherein ring F is as represented by the formula (X) or (X'), and wherein the remaining substituents are as defined herein. Further disclosed is a pharmaceutical composition which comprises a compound as defined above and a pharmaceutically acceptable carrier for the inhibition of the Vascular Endothelial Growth Factor Receptor (VEGFR) and for the treatment of conditions such as angiogenic disorders (including cancer of solid tumors); endometriosis; diabetic retinopathy; psoriasis; hemangioblastoma; Alzheimer's disease; motor neuron disorders (e.g. amyotrophic lateral sclerosis); Parkinson's disease; cerebrovascular disorders (e.g., stroke, ischaemia); Huntington's disease; AIDS dementia; epilepsy; multiple sclerosis; peripheral neuropathies (e.g., those affecting DRG neurons in chemotherapy associated peripheral neuropathy) including diabetic neuropathy; disorders induced by excitatory amino acids; and disorders associated with concussive or penetrating injuries of the brain or spinal cord.
Patent NZ-578381-A (NZ)
Title: New process for the synthesis of agomelatine or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide
Inventor: HARDOUIN CHRISTOPHE
IPC: C07C13/547
Filed: 2009-07-14
Abstract: Disclosed is a process for the industrial synthesis agomelatine, N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, a the compound of formula (I) characterised in that 3-methoxyacenaphthoquinone formula (II) is reacted in the presence of a strong base to yield the compound of formula (III) which is subjected to animation to yield the compound of formula (IV) which is subjected to the action of a reducing system to yield the compound of formula (V) which is successively subjected to the action of sodium acetate and then acetic anhydride to yield the compound of formula (I), which is isolated in the form of a solid.
Patent NZ-578782-A (NZ)
Title: Steering system and method for controlling a train of wheeled vehicles
Inventor: DEMONG MAURICE
IPC: B62D12/00
Filed: 2008-02-07
Abstract: A steering system and method for steering a plurality of vehicles arranged in a train with adjacent vehicles pivotally connected to each other for movement about a vertical axis. Each vehicle (10) has a pair of wheels (64 & 62) mounted on opposite sides of the vehicle steerable by a power actuator mechanism. An electrical control system automatically steers all of the wheels trailing behind the leading pair. Vehicle angle sensors measure intercar angles between adjacent vehicles and provide this information to the control system. An indicator provides the controller with the current distance travelled by the train. Wheel angle sensors provide signals indicative of the current steering angle for each wheel pair. The controller adjusts the actual steering angle for each trailing pair to a desired angle by calculating adjustments based on the measurement inputs.